Emergency* RX takhzyro
Ended Purchase Order Awarded
- Contract number
- 36C24226P1018
- Awardee
-
Theracom, L.L.C. UEI Y12HDHECA8F6
- Awarding agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $78,286
Award facts
- Contract value 100% obligated
- $78,285.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Northport, NY 11768, USA
Award details come from SAM.gov/FPDS.
About this award
Veterans Integrated Service Network 2 (VISN 2) awarded a purchase order to Theracom, L.L.C. for $78,285.92 on September 18, 2026, with completion due September 23, 2026. The order is for TAKHZYRO (lanadelumab and pegtanercept), a high-cost biologic therapy used to treat hereditary angioedema, marked as emergency procurement. Place of performance is Northport, New York. The order uses firm fixed-price pricing on a full-and-open competitive basis with no set-aside.
Quick answers
Who was awarded contract 36C24226P1018?
36C24226P1018 was awarded to Theracom, L.L.C. by Veterans Integrated Service Network 2 (Veterans Health Administration) on September 18, 2026.
How much is contract 36C24226P1018 worth?
The government has obligated $78,286 on 36C24226P1018.
Was contract 36C24226P1018 competed?
The extent of competition for 36C24226P1018 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award